Synvect
Synvect is a biotechnology startup developing CRISPR-based technology to combat mosquito-borne diseases. The company's approach uses CRISPR to produce sterile male mosquitoes to suppress mosquito populations, offering a safe and eco-friendly alternative to traditional pesticides. Synvect is launching pilot programs in high-risk regions after receiving regulatory approval for its first product.
Funding Round: Seed
Funding Amount: $3M
Date: 11-Mar-2025
Investors: Bill & Melinda Gates Foundation, Antler, NuFund, Redbud
Markets: Biotechnology, Healthtech
HQ: San Diego, California, United States
Founded:
Website: https://www.synvect.com/
Leave a Comment
Comments
No comments yet.